Rankings
▼
Calendar
GERN Q2 2024 Earnings — Geron Corporation Revenue & Financial Results | Market Cap Arena
GERN
Geron Corporation
$1B
Q2 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$882,000
+2941.4% YoY
Gross Profit
$865,000
98.1% margin
Operating Income
-$69M
-7860.9% margin
Net Income
-$67M
-7639.8% margin
EPS (Diluted)
$-0.10
QoQ Revenue Growth
+190.1%
Cash Flow
Operating Cash Flow
-$53M
Free Cash Flow
-$54M
Stock-Based Comp.
$13M
Balance Sheet
Total Assets
$449M
Total Liabilities
$143M
Stockholders' Equity
$307M
Cash & Equivalents
$117M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$882,000
$29,000
+2941.4%
Gross Profit
$865,000
$29,000
+2882.8%
Operating Income
-$69M
-$52M
-33.5%
Net Income
-$67M
-$49M
-36.9%
Revenue Segments
Revenues Before Adjustments
$890,000
53%
Product
$780,000
47%
← FY 2024
All Quarters
Q3 2024 →